Edgewise Therapeutics, Inc. (EWTX) vs Indivior Pharmaceuticals Inc (INDV)
A side-by-side comparison of Edgewise Therapeutics, Inc. and Indivior Pharmaceuticals Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
EWTX
Edgewise Therapeutics, Inc.
$40.76HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
INDV
Indivior Pharmaceuticals Inc
$35.57HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — EWTX vs INDV
growth of $100 · dividends reinvested · last 6yEWTX +34.3% (+5.0%/yr)INDV +318.5% (+26.9%/yr)INDV compounded faster over this window
EWTX INDV
EWTX vs INDV: by the numbers
- •INDV is the larger company ($4.44B vs $4.38B market cap).
- •INDV is profitable (26.65% net margin) while EWTX runs a net loss (0.00%).
- •INDV pays a dividend (1.32% yield), while EWTX has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | EWTX | INDV |
|---|---|---|
| P/E ratio | N/A | 12.75 |
| Forward P/E | N/A | 8.43 |
| P/S ratio | N/A | 3.33 |
| P/B ratio | 9.79 | N/A |
| EV / EBITDA | N/A | 8.87 |
Profitability
| Metric | EWTX | INDV |
|---|---|---|
| Gross margin | 0.00% | 83.86% |
| Operating margin | 0.00% | 21.39% |
| Net margin | 0.00% | 26.65% |
| ROE | -44.02% | N/A |
| ROIC | -48.57% | N/A |
Dividends
| Metric | EWTX | INDV |
|---|---|---|
| Dividend yield | N/A | 1.32% |
| Payout ratio | N/A | 17.03% |
Growth (annualized)
| Metric | EWTX | INDV |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 13.88% |
| Total return CAGR (5Y) | 16.95% | 19.65% |
Frequently asked
- Does EWTX or INDV pay a bigger dividend?
- INDV pays a dividend (1.32% yield), while EWTX has no payments in the available dividend history.
- Is EWTX or INDV more profitable?
- INDV runs the higher net margin — EWTX at 0.00% versus INDV at 26.65%.
- How have EWTX and INDV total returns compared?
- Over the past 5 years, EWTX delivered 16.95% and INDV delivered 19.65% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Indivior Pharmaceuticals P/E ratioIndivior Pharmaceuticals dividend yieldEdgewise Therapeutics ROEIndivior Pharmaceuticals ROEEdgewise Therapeutics operating marginIndivior Pharmaceuticals operating marginEdgewise Therapeutics revenue growthIndivior Pharmaceuticals revenue growthEdgewise Therapeutics free cash flowIndivior Pharmaceuticals free cash flow
Edgewise Therapeutics & Indivior Pharmaceuticals appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.